Skip to content

Clinical trials

Phase 1/2 Carcinoma, Hepatocellular trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1/2 Status: Unknown status Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20072
20091
20111
20131
20153
20166
20174
20183
20197
20204
20212
20222
20235
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai GeneChem Co., Ltd.3
Beijing 302 Hospital2
Fudan University2
National Taiwan University Hospital2
Peking Union Medical College Hospital2
PersonGen BioTherapeutics (Suzhou) Co., Ltd.2
Shenzhen BinDeBio Ltd.2
Sun Yat-sen University2
Aronex Pharmaceuticals1
Assiut University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular47
Stomach Neoplasms9
Colorectal Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Pancreatic Neoplasms6
Carcinoma, Renal Cell4
Esophageal Neoplasms4
Liver Neoplasms4
Ovarian Neoplasms4
Melanoma3

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.